NM_000368.5:c.915G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2

The NM_000368.5(TSC1):​c.915G>A​(p.Gly305Gly) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,530,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G305G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000029 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

TSC1
NM_000368.5 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0008443
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7O:1

Conservation

PhyloP100: 0.556

Publications

5 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 9-132911567-C-T is Benign according to our data. Variant chr9-132911567-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 64747.
BP7
Synonymous conserved (PhyloP=0.556 with no splicing effect.
BS2
High AC in GnomAdExome4 at 25 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC1
NM_000368.5
MANE Select
c.915G>Ap.Gly305Gly
splice_region synonymous
Exon 10 of 23NP_000359.1Q92574-1
TSC1
NM_001406626.1
c.-37G>A
5_prime_UTR_premature_start_codon_gain
Exon 9 of 22NP_001393555.1
TSC1
NM_001406627.1
c.-37G>A
5_prime_UTR_premature_start_codon_gain
Exon 9 of 22NP_001393556.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC1
ENST00000298552.9
TSL:1 MANE Select
c.915G>Ap.Gly305Gly
splice_region synonymous
Exon 10 of 23ENSP00000298552.3Q92574-1
TSC1
ENST00000490179.4
TSL:3
c.915G>Ap.Gly305Gly
splice_region synonymous
Exon 11 of 24ENSP00000495533.2Q92574-1
TSC1
ENST00000403810.6
TSL:1
c.915G>Ap.Gly305Gly
splice_region synonymous
Exon 10 of 10ENSP00000386093.1Q86WV8

Frequencies

GnomAD3 genomes
AF:
0.0000291
AC:
4
AN:
137508
Hom.:
0
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000787
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000457
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000797
AC:
2
AN:
250794
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000180
AC:
25
AN:
1392680
Hom.:
0
Cov.:
29
AF XY:
0.0000115
AC XY:
8
AN XY:
693552
show subpopulations
African (AFR)
AF:
0.0000318
AC:
1
AN:
31478
American (AMR)
AF:
0.00
AC:
0
AN:
42970
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35340
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85306
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49896
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4900
European-Non Finnish (NFE)
AF:
0.0000207
AC:
22
AN:
1062122
Other (OTH)
AF:
0.0000355
AC:
2
AN:
56384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000291
AC:
4
AN:
137508
Hom.:
0
Cov.:
28
AF XY:
0.00
AC XY:
0
AN XY:
65450
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
36772
American (AMR)
AF:
0.0000787
AC:
1
AN:
12708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3398
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4324
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
250
European-Non Finnish (NFE)
AF:
0.0000457
AC:
3
AN:
65716
Other (OTH)
AF:
0.00
AC:
0
AN:
1890
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.600
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00000910
Hom.:
0
Bravo
AF:
0.0000264
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Tuberous sclerosis 1 (4)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
not provided (1)
-
1
-
not specified (1)
-
-
1
Tuberous sclerosis syndrome (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
12
DANN
Benign
0.81
PhyloP100
0.56
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=44/56
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00084
dbscSNV1_RF
Benign
0.066
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397515293; hg19: chr9-135786954; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.